NAPSRx

Johnson & Johnson Innovation is known for its modern approach by collaborating with various life science corporations to revolutionize healthcare solutions and discover scientific breakthroughs which will benefit patients worldwide.

The collaboration between Sanofi and Regeneron aims to discover, develop, and commercialize fully-human therapeutic antibodies to treat rare conditions, in this case, moderate to severe atopic dermatitis.(Severe Eczema)

Anacor is a biopharmaceutical company whose focus is towards the discovery, development and commercialization of small molecule therapeutics derived from its novel boron chemistry platform.

Pharmaceutical Sales is one of the highest paid professions in sales and earnings are expected to increase in the coming years. Now is the time to get into this amazing field.

Clinical data catapults FDA approval for belinostat, a new T-cell lymphoma drug that will be sold as Beleodaq from Spectrum Pharmaceuticals.

Acquisition of Seragon Pharmaceuticals will propel Genentech’s oncology R & D pipeline for an effective treatment for hormone receptor-positive breast cancer.

Based on industry analysis, the emerging healthcare market will experience a continuous growth in the pharmaceutical sales sector.

The Breakthrough Designation Therapy for Investigational BiTE® Antibody Blinatumomab is designated for the treatment of Acute Lymphoblastic Leukemia.

MannKind Corporation (Nasdaq:MNKD) is a biopharmaceutical company focused on the innovative breakthrough, development and commercialization of therapeutic products for patients with diseases such as diabetes.

Johnson & Johnson Innovation, LLC focuses on accelerating early-stage innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare business